CompletedNot Applicable

Safety Observation of the Japanese Encephalitis Vaccine Given With a Primary Immunization

China15,357 participantsStarted 2024-01-01

Plain-language summary

This is a single-arm, non-randomized, open-label post-marketing safety observation study. The purpose of this study is to investigate the safety of JEV-I given with primary immunization in a large amount of healthy children aged 8 months and older.

Who can participate

Age range8 Months

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Healthy children who have received the inactivated Japanese encephalitis vaccine. * Legal guardian of the participants voluntarily participates in the clinical trial and signs an informed consent form. * Legal guardian of the subject has the ability to understand the procedures of the study and accept all scheduled visits. Exclusion Criteria: \-

What they're measuring

Number of Participants Reporting Solicited Local and Systemic Adverse Events, and Unsolicited Adverse Events

Timeframe: 30 days following each vaccination

Trial details

NCT IDNCT06372665

SponsorLiaoning Chengda Biotechnology CO., LTD

Sponsor typeINDUSTRY

Study typeOBSERVATIONAL

Primary completion2025-04-30

View on ClinicalTrials.gov More Japanese Encephalitis trials